Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
JAMA
|
December 21, 2017
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew Kanner, et al.
JAMA Oncology
|
October 29, 2020
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial
Timothy F Cloughesy, Kevin Petrecca, Tobias Walbert, et al.
Nature Communications
|
May 13, 2026
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study
Hamed Akbari, Suyash Mohan, Fang Liu, et al.
Neuro-Oncology
|
March 28, 2026
Expanding the molecular grading criteria in IDH-mutant astrocytoma
Michael Christian Virata, Jorge Samanamud, Cheyanne C Slocum, et al.
Scientific Data
|
July 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics
Spyridon Bakas, Chiharu Sako, Hamed Akbari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Louis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, et al.
Nature Cancer
|
January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Stephen J Bagley, Zev A Binder, Lamia Lamrani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2023
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022
Craig Horbinski, Louis Burt Nabors, Jana Portnow, et al.
Cell Reports. Medicine
|
March 31, 2026
A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma
Shiyou Wei, Yulan Deng, Jinho Lee, et al.
Neuro-Oncology
|
March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma
Patrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
JAMA
|
December 21, 2017
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew Kanner, et al.
JAMA Oncology
|
October 29, 2020
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial
Timothy F Cloughesy, Kevin Petrecca, Tobias Walbert, et al.
Nature Communications
|
May 13, 2026
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study
Hamed Akbari, Suyash Mohan, Fang Liu, et al.
Neuro-Oncology
|
March 28, 2026
Expanding the molecular grading criteria in IDH-mutant astrocytoma
Michael Christian Virata, Jorge Samanamud, Cheyanne C Slocum, et al.
Scientific Data
|
July 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics
Spyridon Bakas, Chiharu Sako, Hamed Akbari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Louis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, et al.
Nature Cancer
|
January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Stephen J Bagley, Zev A Binder, Lamia Lamrani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2023
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022
Craig Horbinski, Louis Burt Nabors, Jana Portnow, et al.
Cell Reports. Medicine
|
March 31, 2026
A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma
Shiyou Wei, Yulan Deng, Jinho Lee, et al.
Neuro-Oncology
|
March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma
Patrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Page
of 13